康德萊(603987.SH):H股上市子公司康德萊醫械擬參與“全流通”事項
格隆匯5月25日丨康德萊(603987.SH)公佈,公司第四屆董事會第十五次會議決議,審議通過了《關於H股上市子公司參與全流通事項及公司申請所持內資股股份全流通的議案》;
2019年11月,中國證券監督管理委員會(“中國證監會”)發布了《H股公司境內未上市股份申請“全流通”業務指引》(中國證券監督管理委員會公吿[2019]22號),並配套發佈H股“全流通”申請材料目錄及審核關注要點,全面推開H股“全流通”改革。
公司H股上市子公司康德萊醫械擬參與“全流通”事項,公司擬將所持有的康德萊醫械內資股股份全部轉換為境外上市股份並在香港聯交所主板上市流通,並委託康德萊醫械向中國證監會提出H股“全流通”的申請及辦理其他股份轉換相關事宜。
公司擬將所持有的康德萊醫械內資股股份4285.7142萬股全部申請轉為境外上市股份並在香港聯交所主板上市,轉換股份佔康德萊醫械總股本的25.8176%。
若康德萊醫械股票在本次股份轉換完成前發生送股、資本公積金轉增股本等事項,則本次擬申請轉換的內資股股份數量上限將進行相應調整。
此次股份轉換將在獲得中國證監會關於本次申請核准文件的有效期內擇機完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.